Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype
about
The coreceptor mutation CCR5Delta32 influences the dynamics of HIV epidemics and is selected for by HIVA putative G protein-coupled receptor, RDC1, is a novel coreceptor for human and simian immunodeficiency virusesCCR5, GPR15, and CXCR6 are major coreceptors of human immunodeficiency virus type 2 variants isolated from individuals with and without plasma viremiaHIV-1 gp120 and chemokines activate ion channels in primary macrophages through CCR5 and CXCR4 stimulationEstablishment of a novel CCR5 and CXCR4 expressing CD4+ cell line which is highly sensitive to HIV and suitable for high-throughput evaluation of CCR5 and CXCR4 antagonistsHIV-1 envelope-receptor interactions required for macrophage infection and implications for current HIV-1 cure strategiesBioinformatic analysis of HIV-1 entry and pathogenesis.A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activityVariable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogsInhibitory effects of small-molecule CCR5 antagonists on human immunodeficiency virus type 1 envelope-mediated membrane fusion and viral replicationTwo HIV-1 variants resistant to small molecule CCR5 inhibitors differ in how they use CCR5 for entryThe evolutionary analysis of emerging low frequency HIV-1 CXCR4 using variants through time--an ultra-deep approachImpact of the HIV-1 env genetic context outside HR1-HR2 on resistance to the fusion inhibitor enfuvirtide and viral infectivity in clinical isolatesAllosteric modulation of the HIV-1 gp120-gp41 association site by adjacent gp120 variable region 1 (V1) N-glycans linked to neutralization sensitivityHIV-1 Env C2-V4 diversification in a slow-progressor infant reveals a flat but rugged fitness landscapeSHIV-1157i and passaged progeny viruses encoding R5 HIV-1 clade C env cause AIDS in rhesus monkeysInhibition of HIV-1 endocytosis allows lipid mixing at the plasma membrane, but not complete fusion.Antibody elicited against the gp41 N-heptad repeat (NHR) coiled-coil can neutralize HIV-1 with modest potency but non-neutralizing antibodies also bind to NHR mimetics.Understanding the HIV coreceptor switch from a dynamical perspective.An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10Impact of HIV on cell survival and antiviral activity of plasmacytoid dendritic cellsHIV-1 with multiple CCR5/CXCR4 chimeric receptor use is predictive of immunological failure in infected children.Inhibition of HIV-1 entry by extracts derived from traditional Chinese medicinal herbal plantsReplicative capacity of human immunodeficiency virus type 1 transmitted from mother to child is associated with pediatric disease progression rateHIV-1 clade B Tat, but not clade C Tat, increases X4 HIV-1 entry into resting but not activated CD4+ T cells.Contribution of immunological and virological factors to extremely severe primary HIV type 1 infection.A dual infection/competition assay shows a correlation between ex vivo human immunodeficiency virus type 1 fitness and disease progression.Differential effects of human immunodeficiency virus isolates on beta-chemokine and gamma interferon production and on cell proliferation.Will multiple coreceptors need to be targeted by inhibitors of human immunodeficiency virus type 1 entry?Evolution and biological characterization of human immunodeficiency virus type 1 subtype E gp120 V3 sequences following horizontal and vertical virus transmission in a single family.Role of CXCR4 in cell-cell fusion and infection of monocyte-derived macrophages by primary human immunodeficiency virus type 1 (HIV-1) strains: two distinct mechanisms of HIV-1 dual tropism.R5 strains of human immunodeficiency virus type 1 from rapid progressors lacking X4 strains do not possess X4-type pathogenicity in human thymus.Evolution of the HIV-1 env gene in the Rag2-/- gammaC-/- humanized mouse modelPreferential use of CXCR4 by R5X4 human immunodeficiency virus type 1 isolates for infection of primary lymphocytesHigh systemic levels of interleukin-10, interleukin-22 and C-reactive protein in Indian patients are associated with low in vitro replication of HIV-1 subtype C virusesFunctional chimeras of human immunodeficiency virus type 1 Gp120 and influenza A virus (H3) hemagglutininImpact of viral factors on very early in vivo replication profiles in simian immunodeficiency virus SIVagm-infected African green monkeys.Foot-and-mouth disease virus virulent for cattle utilizes the integrin alpha(v)beta3 as its receptor.Patterns of CCR5, CXCR4, and CCR3 usage by envelope glycoproteins from human immunodeficiency virus type 1 primary isolates.Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1
P2860
Q22066237-ECF0CE50-CC54-4DA5-A32A-08BB15CFD591Q24524308-5F8B8D77-3FA9-4A1E-BAAA-BF36A13197BCQ24557545-83952DBB-92E4-4E43-9D23-B0BB165425B1Q24676438-C030AF14-A131-4C38-AFD4-E241E1B99941Q24802476-87EF0EA6-A40D-4E8B-924E-8C712E4A09A5Q26825087-7A55ED8B-A7FD-49FB-A38C-0E8A778B784FQ27693321-CA32D23A-F8B3-4B23-80CF-2CC672935DBDQ28343321-3D5804E1-B614-4F01-980C-25A2E90214D4Q28344169-7D32719B-D00B-41D2-95B7-97FBD5DE52C7Q28364133-B4D8392F-ACA2-4ACB-8F03-472CBB86259AQ28475912-CA49DBD5-55A6-4785-A10A-91D816EDADDFQ28476558-E9D167AC-D51D-4633-92B3-95D1C6286C36Q28478943-A0F9E7ED-D596-4652-BC3D-879F29064463Q28485983-3C5CE4FF-C32E-45C2-A313-8F5F9504C4F6Q28487168-4DA9F890-51E5-46E4-A2E9-6738A0AC92FAQ30372757-A2C14727-BD18-433C-A3E1-4E5A184ACDEBQ30507959-E2CBDA0B-F664-4A26-AB69-0D271A6215F7Q30843874-3494BE28-BDC9-4FEC-85BD-2D3DC6781D9AQ30931832-9099C81B-7A4C-4949-8319-6127E5AE5369Q33272711-62204071-F26D-4444-B249-F1EAFC1EED64Q33285471-38BC4F8F-0A37-4375-BB84-AC5537A35C62Q33372329-37A5FA29-303A-4181-B04E-D7BB4CC01CABQ33490833-240ED96E-DB5A-4302-BFEC-4FC9DBB1FEC9Q33558599-32A46DED-A332-4BCA-BB14-A1E4E083CD8BQ33581852-EF977976-6444-4B10-A537-822ED8D02FB4Q33589386-EC0E36AD-B97B-43CB-B8E1-C2AAFA93D826Q33604871-85A420EC-81FB-4A5B-BE6E-28DF449D1EA3Q33641854-9E04F486-8301-4D84-9FBC-B8BD7C8C83D9Q33645423-952BB936-8BBE-4AF6-8D4E-93801FA19B6BQ33645838-7AEAA068-7175-4CC8-B9DB-B088A3E9C34BQ33648601-27DEE523-84CD-40AC-801D-18C40C211B86Q33650466-AEE36352-8A9A-404F-9222-316C544A6F20Q33676640-A3A3CADA-C29E-470F-B460-5436703CF1FEQ33716586-1DD8318E-1196-49C7-B8A6-3B9C5CCE7D91Q33736978-7650305F-3CF0-4A1C-97F8-911AF7CF2AFBQ33780529-F24325F4-BB02-4568-AD48-7AE48850C712Q33780668-F93C7736-DF18-4DF5-9E1C-2ADF43A0E95EQ33782587-7AF6E87F-0D32-4F51-A889-8AB30EB23A03Q33782930-2CF6D4CD-43E5-4876-A74A-E1D38CBB4C43Q33785473-9CFF3E13-6C3D-486B-8A6F-F1D8F11676EE
P2860
Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype
description
1997 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1997
@ast
im Oktober 1997 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1997/10/01)
@sk
vědecký článek publikovaný v roce 1997
@cs
wetenschappelijk artikel (gepubliceerd op 1997/10/01)
@nl
наукова стаття, опублікована в жовтні 1997
@uk
مقالة علمية (نشرت في أكتوبر 1997)
@ar
name
Coreceptor usage of primary hu ...... ording to biological phenotype
@ast
Coreceptor usage of primary hu ...... ording to biological phenotype
@en
Coreceptor usage of primary hu ...... ording to biological phenotype
@nl
type
label
Coreceptor usage of primary hu ...... ording to biological phenotype
@ast
Coreceptor usage of primary hu ...... ording to biological phenotype
@en
Coreceptor usage of primary hu ...... ording to biological phenotype
@nl
prefLabel
Coreceptor usage of primary hu ...... ording to biological phenotype
@ast
Coreceptor usage of primary hu ...... ording to biological phenotype
@en
Coreceptor usage of primary hu ...... ording to biological phenotype
@nl
P2093
P2860
P4510
P1433
P1476
Coreceptor usage of primary hu ...... ording to biological phenotype
@en
P2093
A. Björndal
A. Karlsson
C. Colognesi
D. R. Littman
E. M. Fenyö
G. Scarlatti
J. R. Fiore
M. Jansson
P2860
P304
P577
1997-10-01T00:00:00Z